Antisense and RNAi Therapeutics Market

Jan 2021| MRS023A| Market Research Studies

Report Highlights

The scope of this report is broad and covers different Technologies of Antisense and RNAi Therapeutics, along with the applications for Antisense and RNAi Therapeutics and Antisense and RNAi Therapeutics. The market is broken down by technologies of antisense and RNAI therapeutics, applications, and regional markets. Revenue forecasts from 2019 to 2025 are given for each major Technology of Antisense and RNAi Therapeutics, application, and regional market, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional Antisense and RNAi Therapeutics markets; it explains the major market drivers of the global Antisense and RNAi Therapeutics industry, current trends within the industry, major applications, and the regional dynamics of the global Antisense and RNAi Therapeutics market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the global Antisense and RNAi Therapeutics industry.

Report Includes

  • 62 tables
  • An up-to-date analysis of the global Antisense and RNAi Therapeutics market.
  • Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
  • Estimation of market size and revenue forecast for global Antisense and RNAi Therapeutics market, and corresponding market share analysis by Technology, application, route of administration and region for each market segment.
  • Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Antisense and RNAi Therapeutics, identification of the companies that are best positioned to meet this demand.
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
  • Identification of new products and products still in the development and their probability of successful commercial launch within the next five years
  • Impact of COVID-19 on the Antisense and RNAi Therapeutics market as compared to overall global economy.
  • Insight into the growth development strategies of major Antisense and RNAi Therapeutics manufacturers and their key competitive landscape
  • Descriptive company profiles of the leading market participants, including Isis Pharmaceuticals, Antisense Therapeutics, Tekmira Pharmaceuticals, Sanofi, Allergan, Ascletis and AstraZeneca.

Summary.

Antisense and RNAi therapeutics make specific and highly effectual gene silencing possible. Antisense technology provides a chance to influence the expression of gene and therefore, it is regarded as an efficient therapy for targeting ribonucleic acids (RNA). It is mostly used for cardiovascular diseases, oncology, renal diseases, neurodegenerative disorders, respiratory disorders, genetic disorders, infectious diseases, and others.

The Antisense and RNAi therapeutics market based on technology is divided into RNA Interference, siRNA, miRNA and Antisense RNA. In 2020, The Antisense RNA segment is projected to lead the market.

The Global Antisense and RNAi therapeutics market will grow from 1.10 billion in 2020 to 1.11 billion by 2025 at a five-year CAGR of 7.8%. The rising prevalence of diseases is anticipated to contribute to the demand for the antisense & RNAi therapeutics market.

In terms of geography, North America has the significant contribution in the market. The U.S. possesses a multiple number of RNAi therapeutics which are in developmental pipelines. Various biotechnology companies have made substantial high investments for RNAi therapeutic development.

  • Table 1 : Research Programs/Design for This Report
  • Table 2 : Key Data Information from Secondary Sources
  • Table 3 : Key Data Information From Primary Sources
  • Table 4 : Global Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 5 : Global Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 6 : North America Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 7 : North America Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 8 : USA Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 9 : USA Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 10 : Canada Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 11 : Canada Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 12 : Mexico Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 13 : Mexico Antisense and RNAi Therapeutics By Application 2021-2025 (USD Million)
  • Table 14 : Europe Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 15 : Europe Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 16 : Germany Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 17 : Germany Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 18 : France Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 19 : France Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 20 : UK Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 21 : UK Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 22 : Italy Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 23 : Italy Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 24 : Rest Of Europe Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 25 : Rest Of Europe Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 26 : China Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 27 : China Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 28 : Japan Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 29 : Japan Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 30 : India Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 31 : India Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 32 : Korea Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 33 : Korea Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 34 : South East Asia Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 35 : South East Asia Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 36 : Brazil Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 37 : Brazil Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 38 : Argentina Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 39 : Argentina Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 40 : Egypt Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 41 : Egypt Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 42 : Nigeria Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 43 : Nigeria Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 44 : Saudi Arabia Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 45 : Saudi Arabia Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 46 : South Africa Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Table 47 : South Africa Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Table 48 : Gradalis Company Details
  • Table 49 : Gradalis Description And Business Overview
  • Table 50 : Gradalis Financial Analysis
  • Table 51 : Gradalis Product Portfolio
  • Table 52 : Gradalis Recent Development
  • Table 53 : Gene Signal Company Details
  • Table 54 : Gene Signal Description And Business Overview
  • Table 55 : Gene Signal Financial Analysis
  • Table 56 : Gene Signal Product Portfolio
  • Table 57 : Gene Signal Recent Development
  • Table 58 : iCo Therapeutics Company Details
  • Table 59 : iCo Therapeutics Description and Business Overview
  • Table 60 : iCo Therapeutics Financial Analysis
  • Table 61 : iCo Therapeutics Product
  • Table 62 : iCo Therapeutics Recent Development
  • Figure 1 : MRS Methodology For Estimating The Market Demand And Forecast
  • Figure 2 : Bottom-Up And Top-Down Approaches For This Report
  • Figure 3 : Data Triangulation
  • Figure 4 : Global Antisense and RNAi Therapeutics Market By Technology 2021-2025 (USD Million)
  • Figure 5 : Global Antisense and RNAi Therapeutics Market By Growth And Revenue 2021-2025 (USD Million)
  • Figure 6 : Global Antisense and RNAi Therapeutics Market By Application 2021-2025 (USD Million)
  • Figure 7 : Global Antisense and RNAi Therapeutics Market By Country 2021-2025 (USD Million)
  • Figure 8 : Porter's Five Forces Analysis
  • Figure 9 : Channels Of Distribution
  • Figure 10 : Company Profiles
  • Figure 11 : Antisense and RNAi Therapeutics Value Chain Analysis
  • Figure 12 : Global Antisense and RNAi Therapeutics Market Share, By Technology, 2021
  • Figure 13 : Global Antisense and RNAi Therapeutics Market Share, By Application, 2021
  • Figure 14 : Global Antisense and RNAi Therapeutics Market Share, By Region, 2021
  • Figure 15 : Antisense and RNAi Therapeutics Market Overview (Drivers, Restraints, Opportunities)

Market Research Studies is a North Carolina based, premier market research company. MRS brings over 50 years of market research publishing experience. Our reports cover a variety of industries such as Healthcare, Chemicals, Materials & Manufacturing, Research & Diagnostics, Environment & Sustainability, among others. Each year MRS releases hundreds of reports covering various topics. These reports are prepared by our in-house of team of Industry expert analysts. We strive to provide in-depth market analysis with accurate data to help our customers make informed decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report